Teva Pharmaceutical Industries TEVA
NYSE TEVA
$36.58 -0.18 (-0.49%)
As of: Sep 9, 2026 · 2:35 PM EDT

Teva Pharmaceutical Industries (TEVA) Gross Profit Growth (5y) (2014 - 2026)

Analysis

Teva Pharmaceutical Industries (TEVA) Gross Profit Growth (5y) (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.63 Bn 38.97 Bn 2.15 Bn
2 Viatris 19.19 Bn 18.30 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.86 Bn 9.69 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.48 Bn 5.35 Bn 334.51 Mn
5 Bausch Health Companies 2.36 Bn 520.30 Mn 2.10 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 995.52 Mn 705.40 Mn 93.47 Mn
9 Fennec Pharmaceuticals 404.35 Mn 363.10 Mn 17.15 Mn
10 RedHill Biopharma 176.59 Mn 176.59 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.83%
Mar 31, 2026 0.98%
Dec 31, 2025 5.34%
Sep 30, 2025 4.46%
Jun 30, 2025 3.58%
Mar 31, 2025 -1.87%
Dec 31, 2024 1.61%
Sep 30, 2024 3.26%
Jun 30, 2024 1.35%
Mar 31, 2024 -0.93%
Dec 31, 2023 4.16%
Sep 30, 2023 -1.31%
Jun 30, 2023 -2.45%
Mar 31, 2023 -7.33%
Dec 31, 2022 -6.25%
Sep 30, 2022 -8.48%
Jun 30, 2022 -8.53%
Mar 31, 2022 -8.88%
Dec 31, 2021 -9.57%
Sep 30, 2021 -8.53%